SCHEMBL25976552

SCHEMBL25976552

Cc1ccc(-c2cc[n+](C)c(-c3cc(-c4ccccc4)ccc3C)c2)c(C)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
HTT P42858 3/20 0.36
LMNA P02545 2/20 0.36
ESR2 Q92731 1/20 0.36
NPC1 O15118 4/20 0.35
NTSR1 P30989 1/20 0.35
SLC22A2 O15244 1/20 0.34
SLC22A1 O15245 1/20 0.34
SLC22A3 O75751 1/20 0.34
SLC6A4 P31645 1/20 0.34
KDM4E B2RXH2 2/20 0.34
PSMB5 P28074 1/20 0.34
HPRT1 P00492 1/20 0.33
RCE1 Q9Y256 1/20 0.33
TRPA1 O75762 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 3/20 0.33
MEN1 O00255 1/20 0.33
APAF1 O14727 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25976903 0.92 TRPA1 (0.40) RAB9ASMN1; SMN2LMNAESR2NPC1
SCHEMBL25976525 0.89 GRIA1 (0.40) RAB9ASMN1; SMN2HTTLMNANPC1
SCHEMBL25976900 0.89 GRIA1 (0.40) RAB9ASMN1; SMN2HTTLMNANPC1
SCHEMBL25451996 0.89 RAB9A (0.40) RAB9ASMN1; SMN2HTTLMNAESR2
SCHEMBL25976524 0.89 SLC22A2 (0.42) RAB9ASMN1; SMN2HTTLMNANPC1
SCHEMBL25976654 0.86 ESR2 (0.41) RAB9ASMN1; SMN2HTTLMNAESR2
SCHEMBL25452196 0.86 SLC22A2 (0.36) RAB9ASMN1; SMN2HTTLMNANPC1
SCHEMBL25976555 0.85 PSMB5 (0.38) RAB9ASMN1; SMN2HTTLMNANPC1
SCHEMBL25976901 0.83 TRPA1 (0.42) TRPA1ALDH1A1
SCHEMBL25543959 0.83 SLC22A2 (0.42) RAB9ASMN1; SMN2HTTLMNAESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230331758-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-10-19 US disclosed
US-11725021-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-08-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11725021-B2 Organic electroluminescent materials and devices NCL, OCIAD2, OCIAD1 RAB9A 1939/4885SMN1; SMN2 3169/4885HTT 3085/4885
US-20230331758-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES NCL, OCIAD2, OCIAD1 RAB9A 1939/4885SMN1; SMN2 3169/4885HTT 3085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.